Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cronos Group Inc (CRON.TO)

Cronos Group Inc (CRON.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,699,308
  • Shares Outstanding, K 371,806
  • Annual Sales, $ 46,719 K
  • Annual Income, $ -73,137 K
  • 60-Month Beta 1.64
  • Price/Sales 37.31
  • Price/Cash Flow N/A
  • Price/Book 1.29
Trade CRON.TO with:

Options Overview Details

View History
  • Implied Volatility 59.06%
  • Historical Volatility 31.49%
  • IV Percentile 26%
  • IV Rank 16.89%
  • IV High 259.03% on 11/05/20
  • IV Low 18.41% on 05/06/21
  • Put/Call Vol Ratio 0.22
  • Today's Volume 394
  • Volume Avg (30-Day) 179
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 413
  • Open Int (30-Day) 169

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.11
  • Number of Estimates 6
  • High Estimate -0.06
  • Low Estimate -0.15
  • Prior Year -0.05
  • Growth Rate Est. (year over year) -120.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.17 +4.74%
on 09/20/21
8.47 -11.33%
on 09/01/21
-0.39 (-4.94%)
since 08/20/21
3-Month
7.17 +4.74%
on 09/20/21
11.24 -33.19%
on 06/29/21
-2.99 (-28.48%)
since 06/22/21
52-Week
6.55 +14.66%
on 10/02/20
20.08 -62.60%
on 02/10/21
+0.46 (+6.52%)
since 09/22/20

Most Recent Stories

More News
North America CBD Infused Beverages Estimated To Be One of the Largest Sectors in Cannabis Industry Through 2025 - Financial News Media

Palm Beach, FL - September 10, 2021 - FinancialNewsMedia.com News Commentary – Consumers are shifting their preference from soft drinks to wellness drinks leading to the increasing sale of cannabis beverages....

CNFHF : 0.0785 (-2.73%)
CNFA.CN : 0.095 (+5.56%)
WEED.TO : 18.10 (+4.50%)
CGC : 14.17 (+4.81%)
CRON : 5.90 (+4.06%)
CRON.TO : 7.51 (+3.44%)
SRNG : 11.42 (+12.73%)
ACB : 6.01 (-0.33%)
ACB.TO : 7.67 (-0.65%)
HEXO : 1.9200 (-0.52%)
HEXO.TO : 2.46 (unch)
North America CBD Infused Beverages Estimated To Be One of the Largest Sectors in Cannabis Industry Through 2025

/PRNewswire/ --   - Consumers are shifting their preference from soft drinks to wellness drinks leading to the increasing sale of cannabis beverages. Low sugar content in drinks is the major driving factor...

CNFHF : 0.0785 (-2.73%)
CNFA.CN : 0.095 (+5.56%)
WEED.TO : 18.10 (+4.50%)
CGC : 14.17 (+4.81%)
CRON : 5.90 (+4.06%)
CRON.TO : 7.51 (+3.44%)
SRNG : 11.42 (+12.73%)
ACB : 6.01 (-0.33%)
ACB.TO : 7.67 (-0.65%)
HEXO : 1.9200 (-0.52%)
HEXO.TO : 2.46 (unch)
Rising Awareness Of Health Benefits Of "Minor" Cannabinoids Such As CBG, CBDa CBC, CBN Driving U.S. Market

/PRNewswire/ -- - CBD products derived from hemp derived have gained quite a rise in popularity over the past several years, but now, secondary or 'minor' cannabinoids seem to be destined to also have...

CANB : 0.6700 (-3.60%)
TLRY : 11.63 (+3.65%)
TLRY.TO : 14.86 (+3.48%)
CRON : 5.90 (+4.06%)
CRON.TO : 7.51 (+3.44%)
SRNG : 11.42 (+12.73%)
CGC : 14.17 (+4.81%)
WEED.TO : 18.10 (+4.50%)
SNDL : 0.6972 (+0.82%)
Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids

Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group"), an innovative global cannabinoid company, and Ginkgo Bioworks ("Ginkgo"), which is building the leading horizontal platform for cell programming,...

IGLEU : N/A (unch)
CRON : 5.90 (+4.06%)
CRON.TO : 7.51 (+3.44%)
SRNG : 11.42 (+12.73%)
Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at the Canaccord...

CRON : 5.90 (+4.06%)
CRON.TO : 7.51 (+3.44%)
Cronos Group Appoints Bob Madore as Chief Financial Officer

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), an innovative global cannabinoid company, today announced the appointment of Bob Madore as Chief Financial Officer, effective...

CRON : 5.90 (+4.06%)
CRON.TO : 7.51 (+3.44%)
Cronos Group Reports 2021 Second Quarter Results

Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids

CRON : 5.90 (+4.06%)
CRON.TO : 7.51 (+3.44%)
Cronos Group Launches Delicious New Dual-Flavor Cannabis Gummies

SOURZ by Spinach(TM) gummies offer adult consumers a bold and juicy new cannabis edible featuring great tasting dual flavors and dual colors

CRON : 5.90 (+4.06%)
CRON.TO : 7.51 (+3.44%)
CBD Product Sales Could Reach Nearly $17 Billion Dollars In The U.S. Alone By 2025

/PRNewswire/ -- The CBD market has achieved steady growth curve even during the pandemic. CBD or cannabidiol is a natural substance derived from cannabis, found in both marijuana and the non-psychoactive...

OLB : 4.60 (+2.22%)
GRVI : 4.79 (+3.01%)
TLRY : 11.63 (+3.65%)
TLRY.TO : 14.86 (+3.48%)
CGC : 14.17 (+4.81%)
WEED.TO : 18.10 (+4.50%)
CRON : 5.90 (+4.06%)
CRON.TO : 7.51 (+3.44%)
Cronos Group Inc. to Hold 2021 Second Quarter Earnings Conference Call on August 6, 2021

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") will hold its 2021 Second Quarter Earnings Conference Call on Friday, August 6, 2021 at 8:30 a.m. EDT. Cronos Group's senior...

CRON : 5.90 (+4.06%)
CRON.TO : 7.51 (+3.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 7.95
2nd Resistance Point 7.82
1st Resistance Point 7.66
Last Price 7.51
1st Support Level 7.37
2nd Support Level 7.24
3rd Support Level 7.08

See More

52-Week High 20.08
Fibonacci 61.8% 14.91
Fibonacci 50% 13.32
Fibonacci 38.2% 11.72
Last Price 7.51
52-Week Low 6.55

See More

Business Summary

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition,...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar